Page last updated: 2024-08-21

aniline mustard and Benign Neoplasms

aniline mustard has been researched along with Benign Neoplasms in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Denny, WA; Palmer, BD; Pullen, SM; Wilson, WR1
Clarkson, GJ; Liu, J; Paterson, MJ; Prentice, AW; Sadler, PJ; Stavros, VG; Woolley, JM1
Chatzisideri, T; Dalezis, P; Katsamakas, S; Sarli, V; Thysiadis, S; Trafalis, D1
Ferry, DM; Helsby, NA; Patterson, AV; Pullen, SM; Wilson, WR1
Pruijn, FB; Wilson, WR1
Denny, WA; Helsby, NA; Hicks, KO; Hogg, A; Pullen, SM; Wilson, WR1
Bittar, ES; Grabstald, H; Smith, SW; Whitmore, W; Yagoda, A; Young, CW1
Wilman, DE1

Other Studies

8 other study(ies) available for aniline mustard and Benign Neoplasms

ArticleYear
Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:1

    Topics: Alkylation; Aniline Compounds; Aniline Mustard; Antineoplastic Agents; Chemical Phenomena; Chemistry; Chemistry, Physical; Half-Life; Molecular Structure; Neoplasms; Nitrogen Mustard Compounds; Oxidation-Reduction; Oxygen; Structure-Activity Relationship; Tumor Cells, Cultured

1990
A Concerted Redox- and Light-Activated Agent for Controlled Multimodal Therapy against Hypoxic Cancer Cells.
    Advanced materials (Deerfield Beach, Fla.), 2023, Volume: 35, Issue:19

    Topics: Aniline Mustard; Antineoplastic Agents; DNA, Mitochondrial; Humans; Hypoxia; Neoplasms; Oxidation-Reduction; Prodrugs; Reactive Oxygen Species

2023
Novel c(RGDyK)-based conjugates of POPAM and 5-fluorouracil for integrin-targeted cancer therapy.
    Future medicinal chemistry, 2017, Volume: 9, Issue:18

    Topics: A549 Cells; Amino Acid Sequence; Aniline Mustard; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Fluorouracil; Humans; Integrins; Magnetic Resonance Spectroscopy; MCF-7 Cells; Neoplasms; Oligopeptides; Peptides, Cyclic; Propionates

2017
2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT.
    British journal of cancer, 2004, Mar-08, Volume: 90, Issue:5

    Topics: Aniline Mustard; Antineoplastic Agents; Aziridines; Bystander Effect; Chromatography, High Pressure Liquid; Escherichia coli; Genetic Therapy; Genetic Vectors; Humans; Mass Spectrometry; Neoplasms; Nitroreductases; Prodrugs; Structure-Activity Relationship; Tumor Cells, Cultured

2004
Hypoxia-activated prodrugs as antitumour agents: strategies for maximizing tumour cell killing.
    Clinical and experimental pharmacology & physiology, 1995, Volume: 22, Issue:11

    Topics: Aniline Mustard; Animals; Antineoplastic Agents; Cell Hypoxia; Mice; Neoplasms; Nitrogen Mustard Compounds; Prodrugs; Xanthenes; Xanthones

1995
Quantitation of bystander effects in nitroreductase suicide gene therapy using three-dimensional cell cultures.
    Cancer research, 2002, Mar-01, Volume: 62, Issue:5

    Topics: Aniline Mustard; Animals; Aziridines; Bystander Effect; Cell Culture Techniques; Cricetinae; Genetic Therapy; Humans; Neoplasms; Nitroreductases; Prodrugs; Structure-Activity Relationship; Tumor Cells, Cultured

2002
Therapeutic trial of aniline mustard in patients with advanced cancer. Comparison of therapeutic response with cytochemical assessment of tumor cell beta-glucuronidase activity.
    Cancer, 1976, Volume: 38, Issue:5

    Topics: Aniline Mustard; Female; Glucuronidase; Histocytochemistry; Humans; Male; Neoplasms; Nitrogen Mustard Compounds

1976
Prodrugs in cancer chemotherapy.
    Biochemical Society transactions, 1986, Volume: 14, Issue:2

    Topics: Altretamine; Aniline Mustard; Animals; Antineoplastic Agents; Azo Compounds; Biotransformation; Chemistry, Pharmaceutical; Cyclophosphamide; Dacarbazine; Drug Evaluation; Female; Galactosidases; Glucuronosyltransferase; Humans; Imidazoles; Liver; Male; Nausea; Neoplasms; Neoplasms, Experimental; Structure-Activity Relationship; Temozolomide; Vomiting

1986